Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Multicenter, Open-label, Randomized Controlled Trial to Investigate the Effectiveness of Tenofovir Alafenamide in Reducing Clinical Events in Chronic Hepatitis B Patients Beyond Treatment Indications by Current Guidelines

NCT03753074 is registered in ClinicalTrials.gov with Young-Suk Lim as lead sponsor.

NCT NCT03753074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03753074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Multicenter, Open-label, Randomized Controlled Trial to Investigate the Effectiveness of Tenofovir Alafenamide in Reducing Clinical Events in Chronic Hepatitis B Patients Beyond Treatment Indications by Current Guidelines
Lead sponsor
Young-Suk Lim
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 18, 2019
Completion date
December 31, 2031
Enrollment
780 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b